However, combined treatment with similar doses of γ-tocotrienol and rosiglitazone resulted in a significant increase in PGD2 synthesis in PPARγ siRNA transfected MCF-7 and MDA-MB-231 breast cancer cells compared to vehicle-treated or scrambled RNA transfected cells. The gene discussed is PPARG; the disease is breast carcinoma.